Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age
Clinical trial NCT03834688 · COMPLETED
Trial details
- NCT number
- NCT03834688
- Sponsor
- PrECOG, LLC.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-13
- Primary completion
- 2022-10-20
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.